Home > Qtrly Results > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Quarterly Results Analysis [Jun2025]

SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Quarterly Results

Consolidated Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Revenues ₹549 Cr ₹402 Cr ₹307 Cr ₹258 Cr ₹488 Cr ₹253 Cr ₹220 Cr ₹231 Cr
Expenses ₹437 Cr ₹328 Cr ₹189 Cr ₹154 Cr ₹363 Cr ₹180 Cr ₹154 Cr ₹132 Cr
Operating Income ₹112 Cr ₹74 Cr ₹118 Cr ₹104 Cr ₹125 Cr ₹73 Cr ₹66 Cr ₹99 Cr
Other Income ₹14 Cr ₹11 Cr ₹16 Cr ₹14 Cr ₹19 Cr ₹17 Cr ₹14 Cr ₹20 Cr
Interest ₹10 Cr ₹6 Cr ₹3 Cr ₹2 Cr ₹10 Cr ₹2 Cr ₹2 Cr ₹1 Cr
Depreciation ₹45 Cr ₹27 Cr ₹20 Cr ₹17 Cr ₹31 Cr ₹17 Cr ₹13 Cr ₹12 Cr
Profit Before Tax ₹63 Cr ₹52 Cr ₹110 Cr ₹100 Cr ₹103 Cr ₹71 Cr ₹65 Cr ₹105 Cr
Profit After Tax ₹46 Cr ₹39 Cr ₹83 Cr ₹82 Cr ₹75 Cr ₹53 Cr ₹47 Cr ₹80 Cr
EPS ₹1.28 ₹1.65 ₹3.26 ₹3.23 ₹2.96 ₹2.10 ₹1.84 ₹3.12
Industry Peers & Returns1W1M1Y
SUVEN PHARMACEUTICALS 10% 6.3% -15.1%
SUN PHARMACEUTICAL INDUSTRIES 0.7% 0.4% -12.5%
DIVIS LABORATORIES -1.7% 2% 16.7%
CIPLA -0.9% 5.3% -3.7%
TORRENT PHARMACEUTICALS -0.1% 0.6% 6.6%
DR REDDYS LABORATORIES 4.1% 7.6% -3%
MANKIND PHARMA 1.7% 5.8% 6.8%
ZYDUS LIFESCIENCES 2.7% 11.1% -5.8%
LUPIN 2% 3.2% -13.2%

SUVEN PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

36.64 %

Y-o-Y

12.55 %

Quarters Revenues % Change
Jun2025 ₹549 Cr
36.64
Mar2025 ₹402 Cr
30.89
Dec2024 ₹307 Cr
19.18
Sep2024 ₹258 Cr
-47.20
Jun2024 ₹488 Cr
92.97
Mar2024 ₹253 Cr
15.06
Dec2023 ₹220 Cr
-4.86
Sep2023 ₹231 Cr -

SUVEN PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

52.27 %

Y-o-Y

-10.46 %

Quarters Operating Profit % Change
Jun2025 ₹112 Cr
52.27
Mar2025 ₹74 Cr
-37.50
Dec2024 ₹118 Cr
13.16
Sep2024 ₹104 Cr
-16.86
Jun2024 ₹125 Cr
70.58
Mar2024 ₹73 Cr
10.99
Dec2023 ₹66 Cr
-33.01
Sep2023 ₹99 Cr -
Operating Margins
Q-o-Q

11.42 %

Y-o-Y

-20.44 %

Quarters Operating Margin% % Change
Jun2025 20.39%
11.42
Mar2025 18.3%
-52.24
Dec2024 38.32%
-5.05
Sep2024 40.36%
57.47
Jun2024 25.63%
-11.62
Mar2024 29%
-3.53
Dec2023 30.06%
-29.59
Sep2023 42.69% -

SUVEN PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

19.80 %

Y-o-Y

-38.44 %

Quarters Profit After Tax % Change
Jun2025 ₹46 Cr
19.80
Mar2025 ₹39 Cr
-53.50
Dec2024 ₹83 Cr
1.60
Sep2024 ₹82 Cr
8.77
Jun2024 ₹75 Cr
41.22
Mar2024 ₹53 Cr
14.16
Dec2023 ₹47 Cr
-41.23
Sep2023 ₹80 Cr -
PAT Margins
Q-o-Q

-12.25 %

Y-o-Y

-45.27 %

Quarters PAT Margin(%) % Change
Jun2025 8.45 %
-12.25
Mar2025 9.63 %
-64.49
Dec2024 27.12 %
-14.74
Sep2024 31.81 %
106.02
Jun2024 15.44 %
-26.82
Mar2024 21.1 %
-0.80
Dec2023 21.27 %
-38.22
Sep2023 34.43 % -

SUVEN PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-22.42 %

Y-o-Y

-56.76 %

Quarters EPS % Change
Jun2025 ₹1.28
-22.42
Mar2025 ₹1.65
-49.39
Dec2024 ₹3.26
0.93
Sep2024 ₹3.23
9.12
Jun2024 ₹2.96
40.95
Mar2024 ₹2.1
14.13
Dec2023 ₹1.84
-41.03
Sep2023 ₹3.12 -

You may also like the below Video Courses